Kura Oncology's total assets for Q3 2024 were $478.84M, a decrease of -7.04% from the previous quarter. KURA total liabilities were $55.07M for the fiscal quarter, a 12.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.